Page last updated: 2024-08-22

doxifluridine and Soft Tissue Neoplasms

doxifluridine has been researched along with Soft Tissue Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, K; Taniguchi, T; Toi, M; Tominaga, T1
Irie, K; Kawahara, T; Okumura, T; Ota, J; Sakai, K; Shimoyama, T; Taguchi, T; Terasawa, T; Yamamoto, M; Yasutake, K1
Katoh, T; Kawahara, T; Kobayakawa, K; Takatsuka, Y; Tsumura, I1
Abe, O; Ogawa, N; Taguchi, T; Terasawa, T; Tominaga, T; Yoshida, Y1

Trials

2 trial(s) available for doxifluridine and Soft Tissue Neoplasms

ArticleYear
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:6

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy, Radical; Medroxyprogesterone Acetate; Middle Aged; Soft Tissue Neoplasms

1995
[Combination therapy of doxifluridine (5'-DFUR) + cyclophosphamide (CPA) + tamoxifen (TAM) for advanced or recurrent breast cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:9

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Lung Neoplasms; Middle Aged; Soft Tissue Neoplasms; Tamoxifen

1992

Other Studies

2 other study(ies) available for doxifluridine and Soft Tissue Neoplasms

ArticleYear
[Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Papillary; Cyclophosphamide; Drug Administration Schedule; Female; Floxuridine; Humans; Liver Neoplasms; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pleural Neoplasms; Soft Tissue Neoplasms

1992
[A comparative study of 5'-DFUR and tegafur in recurrent breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:10

    Topics: Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Agents; Breast Neoplasms; Capsules; Diarrhea; Drug Administration Schedule; Female; Floxuridine; Humans; Middle Aged; Nausea; Neoplasm Recurrence, Local; Soft Tissue Neoplasms; Tegafur

1985